Celsion Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
42,874.90
36,860.30
20,065.00
4,304.20
24,168.10
27,611.50
Total Accounts Receivable
373.80
210.00
26.70
4.00
54.40
68.30
Other Current Assets
513.40
436.00
189.60
204.40
89.20
451.30
Total Current Assets
43,762.10
37,506.30
20,281.30
4,512.60
24,311.70
28,131.10
Net Property, Plant & Equipment
832.90
1,170.50
854.90
462.80
175.80
184.60
Total Investments and Advances
-
150.00
100.00
100.00
-
-
Intangible Assets
-
27,777.80
27,777.80
25,765.50
23,018.20
18,280.90
Other Assets
1,075.60
89.90
14.40
8.80
8.80
258.90
Total Assets
45,670.60
66,694.50
49,028.40
30,849.70
47,514.40
46,855.60
ST Debt & Current Portion LT Debt
10.90
3,654.20
4,073.70
2,560.60
-
Accounts Payable
1,452.40
3,480.20
2,830.20
2,879.00
3,416.90
Other Current Liabilities
3,207.70
2,956.40
2,419.80
2,983.80
2,782.80
Total Current Liabilities
4,671.00
10,090.80
9,323.70
8,423.30
6,199.70
Long-Term Debt
5,000.00
6,053.10
2,350.00
-
-
Provision for Risks & Charges
-
-
13,921.40
13,188.20
12,538.50
Other Liabilities
4,475.80
17,725.30
3,047.60
2,512.40
2,071.70
Total Liabilities
14,146.70
33,869.20
28,642.70
24,123.90
20,809.90
Common Equity (Total)
31,523.80
32,825.30
20,385.70
6,725.80
26,704.50
Total Shareholders' Equity
31,523.80
32,825.30
20,385.70
6,725.80
26,704.50
Total Equity
31,523.80
32,825.30
20,385.70
6,725.80
26,704.50
Liabilities & Shareholders' Equity
45,670.60
66,694.50
49,028.40
30,849.70
47,514.40

About Celsion

View Profile
Address
997 Lenox Drive
Lawrenceville New Jersey 08648
United States
Employees -
Website http://www.celsion.com
Updated 07/08/2019
Celsion Corp . engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies.